Cargando…
The evolving landscape of prostate cancer stem cell: Therapeutic implications and future challenges
Prostate cancer (PCa) is the most common cause of malignancy in males and the second leading cause of cancer mortality in United States. Current treatments for PCa include surgery, radiotherapy, and androgen-deprivation therapy. Eventually, PCa relapses to an advanced castration-resistant PCa (CRPC)...
Autores principales: | Yun, Eun-Jin, Lo, U-Ging, Hsieh, Jer-Tsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Second Military Medical University
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730868/ https://www.ncbi.nlm.nih.gov/pubmed/29264188 http://dx.doi.org/10.1016/j.ajur.2016.09.006 |
Ejemplares similares
-
The regulatory pathways leading to stem-like cells underlie prostate cancer progression
por: Lin, Chun-Jung, et al.
Publicado: (2019) -
The role of microRNAs in prostate cancer progression
por: Lo, U-Ging, et al.
Publicado: (2013) -
The Role and Mechanism of Epithelial-to-Mesenchymal Transition in Prostate Cancer Progression
por: Lo, U-Ging, et al.
Publicado: (2017) -
The driver role of JAK‐STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy‐ and castration‐resistant prostate cancer
por: Lo, U‐Ging, et al.
Publicado: (2022) -
Evolving Personalized Therapy for Castration-Resistant Prostate Cancer
por: Liu, Hsin-Ho, et al.
Publicado: (2014)